Prognostic Significance of Monocytes and Monocytic Myeloid-Derived Suppressor Cells in Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Prognostic Significance of Monocytes and Monocytic Myeloid-Derived Suppressor Cells in Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Background/Aims: To evaluate the prognostic significance of monocytes and monocytic myeloid-derived suppressor cells (M-MDSCs) for patients with diffuse large B-cell lymphoma (DLBCL) under R-CHOP chemotherapy. Methods: Flow cytometry (FCM) was applied to measure M-MDSCs (CD14+ HLA-DRlow/− M-MDSCs)....

Full description

Bibliographic Details
Main Authors:	Chongyang Wu, Xiangyang Wu, Xiaoning Liu, Peiqi Yang, Juan Xu, Ye Chai, Qi Guo, Zhiping Wang, Liansheng Zhang
Format:	Article
Language:	English
Published:	Cell Physiol Biochem Press GmbH & Co KG 2016-07-01
Series:	Cellular Physiology and Biochemistry
Subjects:	Monocytic myeloid-derived suppressor cells Diffuse large B-cell lymphoma Flow cytometry Chemotherapy
Online Access:	http://www.karger.com/Article/FullText/445644

Similar Items

Monocytic Myeloid-Derived Suppressor Cells But Not Monocytes Predict Poor Prognosis of Acute Myeloid Leukemia
by: Xiyang Ren, et al.
Published: (2022-11-01)

Circulating Myeloid Regulatory Cells: Promising Biomarkers in B-Cell Lymphomas
by: Juliette Ferrant, et al.
Published: (2021-02-01)

Monocytic myeloid-derived suppressor cells as an immune indicator of early diagnosis and prognosis in patients with sepsis
by: Juanjuan Cui, et al.
Published: (2024-04-01)

Increased Monocytic Myeloid-Derived Suppressor Cells in Whole Blood Predict Poor Prognosis in Patients with Plasma Cell Myeloma
by: Mi-Hyun Bae, et al.
Published: (2021-10-01)

Expansion of Monocytic Myeloid-Derived Suppressor Cells in Patients Under Hemodialysis Might Lead to Cardiovascular and Cerebrovascular Events
by: Yan-Fang Xing, et al.
Published: (2021-01-01)

Monocytic-Myeloid Derived Suppressor Cells Suppress T-Cell Responses in Recovered SARS CoV2-Infected Individuals
by: Nadejda Beliakova-Bethell, et al.
Published: (2022-06-01)

Stroke-Induced Modulation of Myeloid-Derived Suppressor Cells (MDSCs) and IL-10-Producing Regulatory Monocytes
by: Lennart Achmus, et al.
Published: (2020-11-01)

Expansion of myeloid-derived suppressor cells in the peripheral blood of patients with ankylosing spondylitis
by: A. Yu. Morenkova, et al.
Published: (2021-05-01)

Co-Occurrence of Myeloid Sarcoma of the Lymph Node and Acute Monocytic Myeloid Leukemia: A Case Report and Literature Review
by: Misbahuddin Khaja, et al.
Published: (2018-11-01)

CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
by: Regina Jitschin, et al.
Published: (2018-11-01)

Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery
by: Xiaosan Su, et al.
Published: (2018-12-01)

Role of Polymorphonuclear Myeloid‐Derived Suppressor Cells and Neutrophils in Ischemic Stroke
by: Haomin Yan, et al.
Published: (2023-03-01)

Monocytic Myeloid-Derived Suppressor Cells Inhibit Myofibroblastic Differentiation in Mesenchymal Stem Cells Through IL-15 Secretion
by: Yin Celeste Cheuk, et al.
Published: (2022-02-01)

Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells
by: Minjun C. Apodaca, et al.
Published: (2019-08-01)

Monocytes in Tumorigenesis and Tumor Immunotherapy
by: Xiaodie Chen, et al.
Published: (2023-06-01)

Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis
by: Yu-feng Liu, et al.
Published: (2018-08-01)

Functional alterations of myeloid cells during the course of Alzheimer’s disease
by: Aaron D. Thome, et al.
Published: (2018-11-01)

Factors Influencing the Differentiation of Human Monocytic Myeloid-Derived Suppressor Cells Into Inflammatory Macrophages
by: Defne Bayik, et al.
Published: (2018-03-01)

Hierarchical Involvement of Myeloid-Derived Suppressor Cells and Monocytes Expressing Latency-Associated Peptide in Plasma Cell Dyscrasias
by: Tamar Tadmor, et al.
Published: (2018-05-01)

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
by: Zhaonian Hao, et al.
Published: (2021-10-01)

The mTOR Deficiency in Monocytic Myeloid-Derived Suppressor Cells Protects Mouse Cardiac Allografts by Inducing Allograft Tolerance
by: Jiawei Li, et al.
Published: (2021-04-01)

Targeting the myeloid microenvironment in neuroblastoma
by: Marjolein C. Stip, et al.
Published: (2023-12-01)

Granulocytic Myeloid-Derived Suppressor Cells (GR-MDSC) in Breast Milk (BM); GR-MDSC Accumulate in Human BM and Modulate T-Cell and Monocyte Function
by: Natascha Köstlin, et al.
Published: (2018-05-01)

Decreased programmed cell death ligand 2-positive monocytic myeloid-derived suppressor cells and programmed cell death protein 1-positive T-regulatory cells in patients with type 2 diabetes: implications for immunopathogenesis
by: Zhaoxiang Liu, et al.
Published: (2023-08-01)

TNFAIP3 Deficiency Affects Monocytes, Monocytes-Derived Cells and Microglia in Mice
by: Francesca Montarolo, et al.
Published: (2020-04-01)

Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
by: Suncica Kapor, et al.
Published: (2021-06-01)

Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies
by: Iosif Papafragkos, et al.
Published: (2021-08-01)

High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure
by: Irene T. Schrijver, et al.
Published: (2022-02-01)

Myeloid-derived suppressor cells in Chronic myeloid leukemia
by: Cesarina eGiallongo, et al.
Published: (2015-05-01)

Discovery of Myeloid-Derived Suppressor Cell-Specific Metabolism by Metabolomic and Lipidomic Profiling
by: Jisu Kim, et al.
Published: (2023-03-01)

Tristetraprolin limits age-related expansion of myeloid-derived suppressor cells
by: Kyu Hwan Kwack, et al.
Published: (2022-10-01)

Myeloid-derived suppressor cells in secondary sepsis: Is there an association with lethal outcome?
by: Udovičić Ivo, et al.
Published: (2020-01-01)

Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3
by: Rosalinda Trovato, et al.
Published: (2019-09-01)

Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy
by: Weitao Zhang, et al.
Published: (2018-01-01)

The Yin and Yang of Myeloid Derived Suppressor Cells
by: Snehil Budhwar, et al.
Published: (2018-11-01)

Valproic acid attenuates CCR2-dependent tumor infiltration of monocytic myeloid-derived suppressor cells, limiting tumor progression
by: Zhiqi Xie, et al.
Published: (2020-01-01)

Elevated circulating myeloid‐derived suppressor cells associated with poor prognosis in B‐cell non‐Hodgkin's lymphoma patients
by: Yangyang Wang, et al.
Published: (2022-05-01)

Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
by: Shunjie Yu, et al.
Published: (2022-07-01)

Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies
by: Vaishali Bhardwaj, et al.
Published: (2023-04-01)

Coordinated Regulation of Myeloid-Derived Suppressor Cells by Cytokines and Chemokines
by: Ru Li, et al.
Published: (2022-02-01)